The central features of diabetes are chronic inflammation and peripheral insulin resistance; accumulating evidence indicated that SCFAs could improve insulin sensitivity and prevent inflammation in in vivo and in vitro models of diabetes (101). Here, INS is linked to diabetes mellitus.